Connection
Michele Fox to Hematologic Neoplasms
This is a "connection" page, showing publications Michele Fox has written about Hematologic Neoplasms.
|
|
Connection Strength |
|
|
|
|
|
0.064 |
|
|
|
-
Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood. 1996 Oct 15; 88(8):3223-9.
Score: 0.064